Aurora Cannabis sees 29% YoY growth and solid cash flow, unaffected by U.S. market fears. Read why ACB stock remains a solid ...

Working capital for the three months ended September 30, 2023 has been adjusted. Refer to discussion under "Liquidity and Capital Resources" section of the MD&A. View ...

Oct. 2, 2024 — Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in ... Cannabinoid CBG Reduces ...

Net income: CA$2.60m (up 40% from 2Q 2024). Profit margin: 3.2% (up from 2.9% in 2Q 2024). EPS: CA$0.05 (up from CA$0.048 in ...

Aurora Cannabis (US) ( (ACB) ) has released its Q2 earnings. Here is a breakdown of the information Aurora Cannabis (US) presented to its ...

Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter.

Q2 2025 Earnings Call Transcript November 6, 2024 Operator: Greetings and welcome to the Aurora Cannabis Inc. Second Quarter 2025 Results Conference Call. all participants will be in a listen-only ...

MedicineHatNews The conversion of the Aurora Sun cannabis greenhouse toward growing flowers and cukes – and the subsequent change in tax status – could negate all other assessment growth in the city ...

Aurora Cannabis Inc (ACB) reports a 29% increase in net revenue, driven by a 93% surge in international medical cannabis ...

Election Day showed varied appetite for cannabis legalization at ballot boxes across the historically-conservative Great Plains.

Or just throw snowballs at a tree. It's like a free rage room. A massage is even better with a hint of cannabis. Head over to ...